ANTI-EPILEPTIC KUNITZ-LIKE PEPTIDES DISCOVERED IN THE BRANCHING CORAL ACROPORA DIGITIFERA THROUGH TRANSCRIPTOMIC ANALYSIS
- Back
Metadata
Share
Title
ANTI-EPILEPTIC KUNITZ-LIKE PEPTIDES DISCOVERED IN THE BRANCHING CORAL ACROPORA DIGITIFERA THROUGH TRANSCRIPTOMIC ANALYSIS
作者
CHEN, HANBIN | SIU, SHIRLEY WENG IN | WONG, CLARENCE TSUN TING | QIU, JIANWEN | CHEUNG, ALEX KWOK-KUEN | LEE, SIMON MING YUEN
PUBLISH YEAR
2022
FACULTY / RESEARCH UNIT
摘要
APPROXIMATELY 50 MILLION PEOPLE ARE SUFFERING FROM EPILEPSY WORLDWIDE. CORALS HAVE BEEN USED FOR TREATING EPILEPSY IN TRADITIONAL CHINESE MEDICINE, BUT THE MECHANISM OF THIS TREATMENT IS UNKNOWN. IN THIS STUDY, WE ANALYZED THE TRANSCRIPTOME OF THE BRANCHING CORAL ACROPORA DIGITIFERA AND OBTAINED ITS KYOTO ENCYCLOPEDIA OF GENES AND GENOMES (KEGG), EUKARYOTIC ORTHOLOGOUS GROUPS (KOG) AND GENE ONTOLOGY (GO) ANNOTATION. COMBINED WITH MULTIPLE SEQUENCE ALIGNMENT AND PHYLOGENETIC ANALYSIS, WE DISCOVERED THREE POLYPEPTIDES, WE NAMED THEM ADKUZ1, ADKUZ2 AND ADKUZ3, FROM A. DIGITIFERA THAT SHOWED A CLOSE RELATIONSHIP TO KUNITZ-TYPE PEPTIDES. MOLECULAR DOCKING AND MOLECULAR DYNAMICS SIMULATION INDICATED THAT ADKUZ1 TO 3 COULD INTERACT WITH GABAA RECEPTOR BUT ADKUZ2–GABAA REMAINED MORE STABLE THAN OTHERS. THE BIOLOGICAL EXPERIMENTS SHOWED THAT ADKUZ1 AND ADKUZ2 EXHIBITED AN ANTI-INFLAMMATORY EFFECT BY DECREASING THE ABERRANT LEVEL OF NITRIC OXIDE (NO), IL-6, TNF-Α AND IL-1Β INDUCED BY LPS IN BV-2 CELLS. IN ADDITION, THE PENTYLENETETRAZOL (PTZ)-INDUCED EPILEPTIC EFFECT ON ZEBRAFISH WAS REMARKABLY SUPPRESSED BY ADKUZ1 AND ADKUZ2. ADKUZ2 PARTICULARLY SHOWED SUPERIOR ANTI-EPILEPTIC EFFECTS COMPARED TO THE OTHER TWO PEPTIDES. FURTHERMORE, ADKUZ2 SIGNIFICANTLY DECREASED THE EXPRESSION OF C-FOS AND NPAS4A, WHICH WERE UP-REGULATED BY PTZ TREATMENT. IN ADDITION, ADKUZ2 REDUCED THE SYNTHESIS OF GLUTAMATE AND ENHANCED THE BIOSYNTHESIS OF GAMMA-AMINOBUTYRIC ACID (GABA). IN CONCLUSION, THE RESULTS INDICATED THAT ADKUZ2 MAY AFFECT THE SYNTHESIS OF GLUTAMATE AND GABA AND ENHANCE THE ACTIVITY OF THE GABAA RECEPTOR TO INHIBIT THE SYMPTOMS OF EPILEPSY. WE BELIEVE, ADKUZ2 COULD BE A PROMISING ANTI-EPILEPTIC AGENT AND ITS MECHANISM OF ACTION SHOULD BE FURTHER INVESTIGATED.
SUBJECTS
ANTI-EPILEPTIC,GABAA,KUNITZ PEPTIDE,TRANSCRIPTOME
DOCUMENT TYPE
Part of
ARCHIVES OF TOXICOLOGY
DOI
10.1007/s00204-022-03311-4
ISSN
1432-0738